Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PHARthis companyPharming Group N.V.	$13.14	441.75×	4.55×	3.35×	35.36×	5.6%	87.9%	5.6%	0.8%	1.0%	1.0%	4.3%	0.42×	-0.87×	1.95×	2.59×	0.0%	5	3.19	3	B+
PRQRProQR Therapeutics N.V.	$1.39	-4.52×	3.12×	11.85×	-2.41×	-3058.3%	83.0%	-275.9%	-265.2%	-69.9%	-42.3%	-29.7%	0.28×	2.49×	-48.66×	3.09×	0.0%	1	-3.3	2	C+
Peer median	—	-4.52×	3.12×	11.85×	-2.41×	-3058.3%	83.0%	-275.9%	-265.2%	-69.9%	-42.3%	-29.7%	0.28×	2.49×	-48.66×	3.09×	0.0%	1	-3.3	2	—